Fast-Acting Therapy: Indian Pharma Broadens Focus Beyond Generics
With forays into medical technology, CDMO, biologics, consumer care, OTC and speciality products, leading Indian pharma companies are rewriting their growth prescription.
India’s Healthcare Crossroads: Is Innovation Enough Without Investment?
India’s healthcare sits at a crossroads—rich in tech innovation but starved of system-wide investment. Coverage is growing, but care still lags. Can we fix systems, not just symptoms?
Fixing Healthcare in India Will Take More Than Just Technology
Experts building India’s future-ready healthcare demands more than apps—it needs smart policy, investment, community skilling, and digital tools
India’s Drug Regulator Wants the World to Rethink Its Assumptions
From stricter standards to cutting-edge therapies, DCGI Dr. Rajeev Singh Raghuvanshi outlines how India is repositioning itself as a global pharmaceutical force.
Empower your business. Get practical tips, market insights, and growth strategies delivered to your inbox
By continuing you agree to our Privacy Policy & Terms & Conditions
